New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
13:41 EDTKOOLHarvest Technologies files amended patent complaint against Thermogenesis
Harvest Technologies announced that it filed an amended patent infringement complaint on February 15 in the US District Court of Delaware against ThermoGenesis (KOOL) and Celling Technologies. The complaint was amended to include Celling Technologies and alleges that the ThermoGenesis' Res-Q 60 BMC system, also sold by Celling Technologies as the ART 21 BMC System, infringes two patents for which Harvest Technology owns the rights. These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration. The complaint also requests an injunction against further sales of the product in the U.S. "Harvest Technologies has invested many years and millions of dollars in development of its cellular therapy products," said Gael Tisack, Vice President of Intellectual Property for Terumo Americas Holding. "We will continue to take all steps necessary to ensure that we protect our intellectual property and enforce our patent rights."
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
20:44 EDTKOOLMarcum to hold a conference
Subscribe for More Information
May 20, 2015
08:18 EDTKOOLCesca Therapeutics receives IEC/IRB approval to initiate AMI study
Subscribe for More Information
May 15, 2015
16:40 EDTKOOLCesca Therapeutics to delay filing Form 10-Q
The registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, within the prescribed time period. As reported in the company’s Form 8-K dated May 12, the former independent registered public accounting firm resigned. The company needs more time to engage a successor independent registered public accounting firm and allow them time to review the management prepared Form 10-Q. No assurance can be given that the company will be able to file its quarterly report within the additional time prescribed by Rule 12b-25.
10:01 EDTKOOLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:10 EDTKOOLCesca Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use